Imagine a common heart condition, often dismissed as benign, silently fueling deadly rhythms in unsuspecting patients. Mitral valve prolapse (MVP), affecting up to 2-3% of the population, has long been viewed as a harmless quirk. Yet, a recent research reveals a subset prone to life-threatening ventricular arrhythmias.
In a groundbreaking cohort study spanning 2009 to 2024, French investigators analyzed 574 carefully selected MVP patients aged 18-70 with preserved ejection fraction and no confounding coronary disease, cardiomyopathies, or channelopathies. The results were published in the Journal of the American Society of Echocardiography.
The study determined the pinpoint determinants of arrhythmogenic MVP (AMVP), defined per European Heart Rhythm Association/Heart Rhythm Society consensus as MVP linked to ventricular tachycardia (VT), ≥5% premature ventricular complexes on Holter, or sudden cardiac arrest (SCA) from VT/ventricular fibrillation, and flag variables tied to SCA or sudden death.
Decoding the Echocardiographic Red Flags
What sets AMVP apart? Echocardiography emerged as a star player. True mitral annular disjunction (MAD), that pathological separation of the mitral annulus from the myocardium, struck 8.0% of AMVP cases versus 3.3% in non-arrhythmic MVP (P=0.013). Even more striking, pseudo-MAD, a subtler variant, plagued 59.4% versus 24.0% (P<0.001). Enter the intriguing "double" and "triple" e' patterns on tissue Doppler—hallmarks of abnormal early diastolic filling—seen in 70.4% and 43.9% of AMVP patients, dwarfing the 31.3% and 18.2% in controls (both P<0.001). These findings indicates heightened longitudinal strain and myocardial work indices in the basal and mid inferolateral and anterolateral left ventricular walls, hinting at fibrosis-prone hotspots vulnerable to ectopy.
CMR and Strain Imaging
Cardiac magnetic resonance (CMR) amplified the clues, corroborating MAD's role and unveiling myocardial irregularities. Independent predictors of AMVP boiled down to MAD/pseudo-MAD distance, double-peak strain, "double" e' pattern, and peak strain dispersion, echo parameters clinicians can readily harness. Holter monitoring spotlighted VT burden, while ECG has T-wave inversions in precordial leads. In this cohort (mean age 38.5 years, 65% women), these multiparametric signals painted a profile of "malignant MVP," where papillary muscle origins of arrhythmias lurk beneath preserved global function.
Toward Precision Risk Stratification
SCA/sudden death risk demands a comprehensive analysis: integrate clinical history, ECG quirks, Holter metrics, and layered imaging. Routine screening for MAD (true or pseudo), diastolic Doppler oddities, and regional strain/work anomalies could triage high-risk phenotypes early, potentially averting catastrophes via ablation or defibrillators. As MVP patients skew young and female, this work urges vigilance beyond bileaflet prolapse; think high-risk "bileaflet with MAD" or isolated posterior leaflet variants.
These insights from 3,325 screened patients challenge dogma, empowering echocardiographers and electrophysiologists to spot the arrhythmic time bomb. Forward-thinking protocols might integrate AI-driven strain analysis with Holter data for real-time alerts. For the frontline physician, it's a call: next MVP echo, probe those inferolateral walls and annulus diligently.